Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest marketbeat.com · about 19 hours ago

Urogen Pharma Q2 Earnings Call Highlights

Urogen Pharma NASDAQ: URGN reported second-quarter 2026 revenue of $72.5 million, up from $24.2 million a year earlier, as the commercial launch of bladder cancer treatment ZUSDURI continued to gain traction. The company recorded a net loss of $14.4 million, or $0.28 per share, compared with a $49.9 million loss, or $1.05 per share, in the prior-year quarter.

Stocks

More recent coverage

Page 99
UTHR marketbeat.com · about 19 hours ago

United Therapeutics Q2 Earnings Call Highlights

United Therapeutics NASDAQ: UTHR reported second-quarter 2026 revenue of approximately $783 million, essentially flat from the first quarter, as competitive pressure affected sales of its nebulized TYVASO therapy. Company executives said they expect stronger performance in the second half of the year but did not reaffirm or update previous 2026 revenue-growth expectations.

WEYS marketbeat.com · about 19 hours ago

Weyco Group Q2 Earnings Call Highlights

Weyco Group NASDAQ: WEYS reported higher second-quarter sales and sharply increased earnings, with results substantially supported by tariff refunds following the invalidation of certain import duties by the U.S. Supreme Court.

WULF marketbeat.com · about 19 hours ago

TeraWulf Q2 Earnings Call Highlights

TeraWulf NASDAQ: WULF said its second-quarter results reflected growing high-performance computing, or HPC, lease revenue as additional capacity came online at its Lake Mariner campus, alongside a broader expansion strategy that includes a major Anthropic lease in Kentucky, the acquisition of the Muskie Data Campus and a planned sale of its interest in the Abernathy joint venture.

TEVA seekingalpha.com · about 19 hours ago

Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan

Teva Pharmaceutical Industries Limited is executing a successful turnaround, driven by its "Pivot to Growth" strategy and strong innovative medicines performance. Management raised 2026 guidance for Austedo, Ajovy, and Uzedy, targeting $3.7B specialty revenue (17% y/y growth) and a robust pipeline through 2030. Generics and biosimilars remain stable, funding R&D for innovation, while margin improvements and debt reduction enhance the risk/reward profile.

XPEL marketbeat.com · about 19 hours ago

XPEL Q2 Earnings Call Highlights

XPEL NASDAQ: XPEL reported record second-quarter revenue as growth in the United States, China and other Asia-Pacific markets offset continued pressure in dealerships, softer European results and a decline in India and Middle East revenue tied partly to vehicle availability.

ADNT marketbeat.com · about 19 hours ago

Adient Q3 Earnings Call Highlights

Adient NYSE: ADNT reported third-quarter fiscal 2026 revenue of approximately $3.9 billion, up 5% from a year earlier, while adjusted EBITDA was flat at $225 million as conflict-related commodity and freight costs, customer production disruptions and operating inefficiencies weighed on profitability.

GOOG pymnts.com · about 19 hours ago

Google Eyes $1.5 Billion Mechanize Deal to Enhance AI Coding

Google is in talks with artificial intelligence coding agent startup Mechanize to hire some of Mechanize's talent and sign a non-exclusive licensing agreement for the company's technology, Business Insider reported Wednesday (Aug. 5), citing unnamed sources. The potential deal is worth over $1.

AIZ marketbeat.com · about 19 hours ago

Assurant Q2 Earnings Call Highlights

Assurant NYSE: AIZ reported a second consecutive quarter of record earnings in the second quarter of 2026, supported by growth in its Global Lifestyle and Global Housing businesses. Management raised its full-year outlook, citing program expansion, improving operating performance and continued capital returns.

ETSY prnewswire.com · about 19 hours ago

Etsy, Inc. Reports Second Quarter 2026 Results

BROOKLYN, N.Y., Aug. 5, 2026 /PRNewswire/ -- Etsy, Inc. (NYSE: ETSY), which owns and operates the Etsy marketplace, the global destination for unique and creative goods, today announced results for its second quarter ended June 30, 2026.

EBIT prnewswire.com · about 19 hours ago

Honeywell Aerospace reports second quarter results; updates 2026 outlook

Sales of $4.5 billion, reported and organic1 sales up 5% year over year Net income of $0.3 billion and adjusted EBIT1 of $1.0 billion, excluding pro forma standalone adjustments Revises full-year sales and pro forma standalone adjusted EBIT1 guidance and issues full-year pro forma standalone adjusted earnings per share1 guidance Completed spin-off from Honeywell Technologies on June 29  PHOENIX, Aug. 5, 2026 /PRNewswire/ -- Honeywell Aerospace (Nasdaq: HONA) today announced results for the second quarter following the completion of its spin-off from Honeywell International Inc. ("Honeywell Technologies", Nasdaq: HON). The company also updated its full-year 2026 outlook for organic1 sales and pro forma standalone adjusted EBIT1, initiated full-year 2026 pro forma standalone adjusted earnings per share1 guidance, and maintained its second half 2026 free cash flow1 guidance range.

WES prnewswire.com · about 19 hours ago

Western Midstream Announces Second-Quarter 2026 Results and Revised Full-year Guidance

Reported second-quarter 2026 Net income attributable to limited partners of $394.9 million, generating record quarterly Adjusted EBITDA(1) of $736.5 million, which represents a 19-percent increase compared to the prior-year period, and second-quarter Distributable Cash Flow(1) of $537.2 million. Reported second-quarter 2026 Cash flows provided by operating activities of $534.7 million, generating second-quarter Free Cash Flow(1) of $263.6 million.

← Newer
Older →